Today
+0.48%
5 Days
+0.33%
1 Month
-6.28%
6 Months
-1.86%
Year to Date
+12.81%
1 Year
+0.23%
• Corteva missed second-quarter revenue and earnings estimates, prompting lowered full-year EBITDA guidance. • Declining crop protection demand and lower commodity prices have reduced farmer spending power. • Analysts downgraded the stock following poor financial results and inventory destocking by distributors.
• Linde lowered full-year sales volume guidance citing cooling industrial demand in Europe and China. • High capital expenditure for clean energy projects is pressuring short-term free cash flow. • Brokerage firms lowered price targets amid concerns over a slump in semiconductor gas demand.
• Analysts raised price targets citing Linde’s pricing power and strong market demand. • Market optimism increased ahead of the second-quarter earnings release scheduled this month. • Linde’s long-term contract model and secular growth exposure continue attracting institutional capital.
• Air Products cancelled the Louisiana Clean Energy Complex project to improve capital discipline. • The company will incur pre-tax charges up to $2.9 billion by fiscal 2026. • Management is partnering with Yara International to market renewable ammonia from the NEOM project.
• Growing lithium demand from electric vehicles drives Albemarle. • Analyst upgrades and earnings estimate revisions boost Albemarle. • Cost savings and portfolio adjustments enhance Albemarle's profitability.
• Linde plc beat Q1 2026 earnings and revenue expectations. • Analysts maintain "Buy" ratings and raised price targets for Linde. • Growth drivers include space, hydrogen, electronics, and clean energy projects.


| Shareholders | Proportion |
|---|---|
| Vanguard Capital Management, LLC | 6.54% |
| BlackRock Institutional Trust Company, N.A. | 4.99% |
| State Street Investment Management (US) | 4.19% |
| Vanguard Portfolio Management, LLC | 2.66% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 52.38% |
| Investment Advisor/Hedge Fund | 23.45% |
| Research Firm | 3.49% |
| Pension Fund | 2.85% |
Related Instruments
Popular Instruments